The dates and venue for the upcoming Hematology event will be announced shortly.
For further details, Please contact us at secretary@magnusmeetings.com or call + 1 (702) 988 2320.
COVID-19 (SARS-CoV-2) infection has been taking on pandemic dimensions. Preventive infection measures, as well as epidemiological, pathophysiological, diagnostic, and treatment expertise, are desperately needed for this virus. Advances in diagnostic tests, whether for antibody detection through "fast" tests or for detecting the presence of the virus (using the technique of RT-PCR of respiratory samples from affected patients), are critical because they aid in epidemiology, case tracking, and outbreak containment, as well as earlier disease diagnosis, which leads to a better outcome, especially in severe cases. Lymphocytopenia, thrombocytopenia, and increased D-dimer levels are all common haematological anomalies in COVID-19. These changes are more widespread and evident in patients with severe COVID-19 disease, suggesting that they could be used as a biomarker for those who require hospitalisation and intensive care unit care. Early in the course of COVID-19 infection, subtle haematological alterations may develop; increasing disease is associated with considerable haematological abnormalities that may guide the therapeutic plan and predict patient fate.
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan Lluis Vives Corrons, Institute for Leukaemia Research Josep Carreras, Spain
Title : Histologic transformation of mantle zone lymphoma to diffuse large B-Cell lymphoma: A case report of disease relapse after Covid-19 infection
Lilija Bancevica, Riga Stradins University, Latvia
Title : Improving outcomes of curable lymphoma in resource constrained regions
Reena Nair, TATA Medical Centre, India
Title : Covid-19 and erythrocyte groups
Marina Nagervadze, Batumi Shota Rustaveli State University, Georgia
Title : Achieving 100% blood traceability compliance: A United Kingdom district hospital experience
Francis Ajeneye, Princess Alexandra Hospital NHS Trust, United Kingdom
Title : Role of erythrocytapheresis in sickle cell anemia crisis management: A tertiary care centre experience from Chhattisgarh state of central India
Neelesh Jain, Transfusion Medicine at Balco Medical Centre, India